HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.

Abstract
Kaposi sarcoma, the most common cancer in HIV-positive individuals, is caused by endothelial transformation mediated by the Kaposi sarcoma herpes virus (KSHV)-encoded G-protein-coupled receptor (vGPCR). Infection of blood vascular endothelial cells (BEC) by KSHV reactivates an otherwise silenced embryonic program of lymphatic differentiation. Thus, Kaposi sarcoma tumors express numerous lymphatic endothelial cell (LEC) signature genes. A key unanswered question is how lymphatic reprogramming by the virus promotes tumorigenesis leading to Kaposi sarcoma formation. In this study, we present evidence that this process creates an environment needed to license the oncogenic activity of vGPCR. We found that the G-protein regulator RGS4 is an inhibitor of vGPCR that is expressed in BECs, but not in LECs. RGS4 was downregulated by the master regulator of LEC differentiation PROX1, which is upregulated by KSHV and directs KSHV-induced lymphatic reprogramming. Moreover, we found that KSHV upregulates the nuclear receptor LRH1, which physically interacts with PROX1 and synergizes with it to mediate repression of RGS4 expression. Mechanistic investigations revealed that RGS4 reduced vGPCR-enhanced cell proliferation, migration, VEGF expression, and Akt activation and suppressed tumor formation induced by vGPCR. Our findings resolve long-standing questions about the pathologic impact of KSHV-induced reprogramming of host cell identity, and they offer biologic and mechanistic insights supporting the hypothesis that a lymphatic microenvironment is more favorable for Kaposi sarcoma tumorigenesis.
AuthorsBerenice Aguilar, Inho Choi, Dongwon Choi, Hee Kyoung Chung, Sunju Lee, Jaehyuk Yoo, Yong Suk Lee, Yong Sun Maeng, Ha Neul Lee, Eunkyung Park, Kyu Eui Kim, Nam Yoon Kim, Jae Myung Baik, Jae U Jung, Chester J Koh, Young-Kwon Hong
JournalCancer research (Cancer Res) Vol. 72 Issue 22 Pg. 5833-42 (Nov 15 2012) ISSN: 1538-7445 [Electronic] United States
PMID22942256 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2012 AACR.
Chemical References
  • Homeodomain Proteins
  • RGS Proteins
  • RNA, Messenger
  • Receptors, G-Protein-Coupled
  • Tumor Suppressor Proteins
  • prospero-related homeobox 1 protein
  • RGS4 protein
  • Oncogene Protein v-akt
Topics
  • Animals
  • Cell Differentiation (physiology)
  • Cell Transformation, Viral
  • Down-Regulation
  • Endothelial Cells (metabolism, pathology, virology)
  • Female
  • Herpesvirus 8, Human (genetics, metabolism, physiology)
  • Homeodomain Proteins (genetics, metabolism)
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Mice, Nude
  • Mice, SCID
  • Oncogene Protein v-akt (metabolism)
  • Promoter Regions, Genetic
  • RGS Proteins (antagonists & inhibitors, biosynthesis, genetics)
  • RNA, Messenger (biosynthesis, genetics)
  • Receptors, G-Protein-Coupled (genetics, metabolism, physiology)
  • Tumor Suppressor Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: